Diffuse large B-cell non-Hodgkin's lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Ann Oncol. 2010 May:21 Suppl 5:v172-4. doi: 10.1093/annonc/mdq203.
No abstract available

Publication types

  • Practice Guideline
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antigens, CD20 / metabolism
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • CD13 Antigens / metabolism
  • Europe / epidemiology
  • Follow-Up Studies
  • Humans
  • Incidence
  • Leukocyte Common Antigens / metabolism
  • Lymphoma, B-Cell / diagnosis*
  • Lymphoma, B-Cell / drug therapy
  • Lymphoma, B-Cell / therapy*
  • Neoplasm Staging
  • Randomized Controlled Trials as Topic
  • Risk Assessment
  • Secondary Prevention
  • Treatment Outcome

Substances

  • Antigens, CD20
  • Leukocyte Common Antigens
  • CD13 Antigens